[(E,2R)-2-[(8S,9R,10R,13R,14S,16R,17R)-2,16-dihydroxy-4,4,9,13,14-pentamethyl-3,11-dioxo-8,10,12,15,16,17-hexahydro-7H-cyclopenta[a]phenanthren-17-yl]-6-hydroxy-6-methyl-3-oxohept-4-en-2-yl] acetate

Term ID

CHEBI:182058

Synonyms

[(E,2R)-2-[(8S,9R,10R,13R,14S,16R,17R)-2,16-dihydroxy-4,4,9,13,14-pentamethyl-3,11-dioxo-8,10,12,15,16,17-hexahydro-7H-cyclopenta[a]phenanthren-17-yl]-6-hydroxy-6-methyl-3-oxohept-4-en-2-yl] acetate

Definition

References

Chemspider:22943329

Ontology

ChEBI ( EBI )

Relationships

is a type of: cucurbitacin

cucurbitacin Show first 5 Terms

Phenotype

Phenotype resulting from [(E,2R)-2-[(8S,9R,10R,13R,14S,16R,17R)-2,16-dihydroxy-4,4,9,13,14-pentamethyl-3,11-dioxo-8,10,12,15,16,17-hexahydro-7H-cyclopenta[a]phenanthren-17-yl]-6-hydroxy-6-methyl-3-oxohept-4-en-2-yl] acetate

Phenotype where environments contain [(E,2R)-2-[(8S,9R,10R,13R,14S,16R,17R)-2,16-dihydroxy-4,4,9,13,14-pentamethyl-3,11-dioxo-8,10,12,15,16,17-hexahydro-7H-cyclopenta[a]phenanthren-17-yl]-6-hydroxy-6-methyl-3-oxohept-4-en-2-yl] acetate

Phenotype modified by environments containing [(E,2R)-2-[(8S,9R,10R,13R,14S,16R,17R)-2,16-dihydroxy-4,4,9,13,14-pentamethyl-3,11-dioxo-8,10,12,15,16,17-hexahydro-7H-cyclopenta[a]phenanthren-17-yl]-6-hydroxy-6-methyl-3-oxohept-4-en-2-yl] acetate

Human Disease Model